| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/12/264:05 PM | -$0.31 | -$0.28GAAP | +9.7% | -33% | — | $0 | — | — | |
| Q2 '26 | 8/13/268:05 AM | -$0.23 | -$0.52GAAP | -126% | -478% | — | $0 | — | — | |
| Q1 '26 | 5/14/262:05 PM | -$0.30 | -$0.14GAAP | +53.3% | -208% | — | $0 | — | — | |
| Q4 '25 | 3/12/268:05 AM | -$0.24 | -$0.54GAAP | -125% | -35% | — | $0 | — | — | |
| Q3 '25 | 11/13/258:25 AM | -$0.17 | -$0.21GAAP | -23.5% | +36% | — | $0 | — | — | |
| Q2 '25 | 8/14/258:05 AM | -$0.17 | -$0.09GAAP | +47.1% | ⚠ Check | — | $0 | — | — | |
| Q1 '25 | 5/13/258:00 AM | -$0.24 | $0.13GAAP | +154% | +146% | — | $0 | — | — |
⚠ Potential error in calculation, check manually. The two EPS figures may be on different share counts (a stock split one source has not adjusted for).
GAAP = diluted EPS as filed with the SEC.